A systematic classification of megakaryocytic dysplasia and its impact on prognosis for patients with myelodysplastic syndromes

BACKGROUND: Dys-megakaryopoiesis is defined as ≥10 % of dysplastic megakaryocytes in bone marrow smears by the World Health Organization. However, concordance rates for dysplastic megakaryocytes between different observers is low and, consequently, evaluation of dysmegakaryopoiesis is also often dis...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Exp Hematol Oncol
Päätekijät: Feng, Gege, Gale, Robert Peter, Cui, Wen, Cai, Wenyu, Huang, Gang, Xu, Zefeng, Qin, Tiejun, Zhang, Yue, Li, Bing, Fang, Liwei, Zhang, Hongli, Pan, Lijuan, Hu, Naibo, Qu, Shiqiang, Wang, Jingya, Cui, Yajuan, Xiao, Zhijian
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2016
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4848808/
https://ncbi.nlm.nih.gov/pubmed/27127725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40164-016-0041-6
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia